Therapeutic Area | MeSH |
---|---|
urogenital diseases | D000091642 |
signs and symptoms pathological conditions | D013568 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
PITOCIN | Endo | N-018261 RX | 1982-01-01 | 3 products, RLD, RS |
OXYTOCIN | Fresenius Kabi | N-018248 RX | 1982-01-01 | 3 products, RLD, RS |
OXYTOCIN | Hikma Pharmaceuticals | N-018243 RX | 1982-01-01 | 2 products, RLD, RS |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
postpartum hemorrhage | — | D006473 | O72 |
Code | Description |
---|---|
J2590 | Injection, oxytocin, up to 10 units |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hemorrhage | D006470 | MP_0001914 | R58 | 16 | 17 | 28 | 30 | 81 | 166 |
Postpartum hemorrhage | D006473 | — | O72 | 13 | 14 | 25 | 23 | 73 | 144 |
Healthy volunteers/patients | — | — | — | 17 | 3 | 1 | 1 | 40 | 62 |
Schizophrenia | D012559 | EFO_0000692 | F20 | 9 | 9 | — | 2 | 15 | 34 |
Induced labor | D007751 | — | — | 2 | 4 | 3 | 6 | 19 | 34 |
Autistic disorder | D001321 | HP_0000717 | F84.0 | 7 | 20 | 3 | 1 | 4 | 33 |
Autism spectrum disorder | D000067877 | HP_0000729 | F84.0 | 7 | 18 | 3 | 1 | 3 | 30 |
Obstetric labor complications | D007744 | — | — | 2 | 4 | 2 | 2 | 17 | 25 |
Cesarean section | D002585 | — | — | 2 | 1 | 3 | 4 | 13 | 22 |
Pregnancy | D011247 | EFO_0002950 | Z33.1 | 1 | — | 2 | 2 | 15 | 20 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Alcoholism | D000437 | EFO_0003829 | F10.1 | 6 | 14 | 3 | — | — | 22 |
Syndrome | D013577 | — | — | 3 | 9 | 5 | — | 3 | 16 |
Prader-willi syndrome | D011218 | Orphanet_739 | Q87.11 | 4 | 8 | 5 | — | 3 | 15 |
Depression | D003863 | — | F33.9 | 1 | 3 | 1 | — | 9 | 13 |
Alcohol drinking | D000428 | EFO_0004329 | — | 2 | 7 | 1 | — | — | 9 |
Pre-eclampsia | D011225 | EFO_0000668 | O14 | 1 | — | 2 | — | 5 | 8 |
Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | 8 | 1 | — | — | 8 |
Atrophy | D001284 | — | — | — | 6 | 2 | — | — | 7 |
Atrophic vaginitis | D059268 | EFO_1001271 | — | — | 5 | 2 | — | — | 6 |
Cocaine-related disorders | D019970 | — | F14 | 2 | 4 | 1 | — | 1 | 6 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Postpartum depression | D019052 | EFO_0007453 | F53.0 | — | 2 | — | — | 7 | 9 |
Depressive disorder | D003866 | EFO_1002014 | F32.A | 1 | 2 | — | — | 6 | 9 |
Opioid-related disorders | D009293 | EFO_0005611 | F11 | 6 | 2 | — | — | — | 7 |
Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | 1 | 2 | — | — | 4 | 7 |
Psychotic disorders | D011618 | — | F20.81 | 4 | 1 | — | — | 3 | 7 |
Social cognition | D000083282 | — | — | 5 | 1 | — | — | — | 6 |
Postoperative hemorrhage | D019106 | — | — | 1 | 1 | — | — | 4 | 5 |
Dementia | D003704 | EFO_0003862 | F03 | 1 | 3 | — | — | 1 | 5 |
Frontotemporal dementia | D057180 | HP_0002145 | G31.0 | 1 | 2 | — | — | 1 | 4 |
Primary progressive aphasia | D018888 | EFO_0009053 | G31.01 | 1 | 2 | — | — | 1 | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Personality disorders | D010554 | HP_0012075 | F60.6 | 1 | — | — | — | 6 | 7 |
Borderline personality disorder | D001883 | HP_0012076 | F60.3 | 1 | — | — | — | 5 | 6 |
Embryo transfer | D004624 | — | — | 4 | — | — | — | — | 4 |
Social psychology | D011593 | — | — | 3 | — | — | — | — | 3 |
High-risk pregnancy | D018566 | — | — | 1 | — | — | — | 2 | 3 |
Antisocial personality disorder | D000987 | — | F60.2 | 1 | — | — | — | 2 | 3 |
Stroke | D020521 | EFO_0000712 | I63.9 | 1 | — | — | — | 1 | 2 |
Emotions | D004644 | — | — | 1 | — | — | — | 1 | 2 |
Parent-child relations | D010287 | — | — | 1 | — | — | — | 1 | 2 |
Fetal growth retardation | D005317 | EFO_0000495 | — | 1 | — | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Placenta accreta | D010921 | EFO_0007440 | O43.21 | — | — | — | — | 5 | 5 |
Breast feeding | D001942 | — | — | — | — | — | — | 5 | 5 |
Pathologic dilatation | D004108 | — | — | — | — | — | — | 3 | 3 |
Vaginal birth after cesarean | D016064 | — | — | — | — | — | — | 3 | 3 |
Hypertension | D006973 | EFO_0000537 | I10 | — | — | — | — | 3 | 3 |
Gestational diabetes | D016640 | HP_0009800 | O24.4 | — | — | — | — | 3 | 3 |
Morbid obesity | D009767 | EFO_0001074 | — | — | — | — | — | 3 | 3 |
Infertility | D007246 | HP_0000789 | — | — | — | — | — | 2 | 2 |
Placebos | D010919 | — | — | — | — | — | — | 2 | 2 |
Premature obstetric labor | D007752 | — | O60 | — | — | — | — | 2 | 2 |
Drug common name | Oxytocin |
INN | oxytocin |
Description | Oxytocin is a cyclic nonapeptide hormone with amino acid sequence CYIQNCPLG that also acts as a neurotransmitter in the brain; the principal uterine-contracting and milk-ejecting hormone of the posterior pituitary. Together with the neuropeptide vasopressin, it is believed to influence social cognition and behaviour. It has a role as an oxytocic and a vasodilator agent. It is a peptide hormone and a heterodetic cyclic peptide. |
Classification | Protein |
Drug class | oxytocin derivatives |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O |
PDB | — |
CAS-ID | 50-56-6 |
RxCUI | — |
ChEMBL ID | CHEMBL395429 |
ChEBI ID | 7872 |
PubChem CID | 439302 |
DrugBank | DB00107 |
UNII ID | 1JQS135EYN (ChemIDplus, GSRS) |